ClinicalTrials.gov record
Completed Phase 2 Interventional Results available

Study To Evaluate Safety And Efficacy Of PF-06700841 In Subjects With Moderate To Severe Plaque Psoriasis

ClinicalTrials.gov ID: NCT02969018

Public ClinicalTrials.gov record NCT02969018. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Apr 29, 2026, 9:42 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A PHASE 2A, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY TO EVALUATE SAFETY AND EFFICACY OF PF-06700841 IN SUBJECTS WITH MODERATE TO SEVERE PLAQUE PSORIASIS

Study identification

NCT ID
NCT02969018
Recruitment status
Completed
Study type
Interventional
Phase
Phase 2
Lead sponsor
Pfizer
Industry
Enrollment
212 participants

Conditions and interventions

Interventions

  • PF-06700841 Drug
  • Placebo Other

Drug · Other

Eligibility (public fields only)

Age range
18 Years to 75 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Nov 30, 2016
Primary completion
Feb 28, 2018
Completion
Feb 28, 2018
Last update posted
Mar 28, 2019

2016 – 2018

United States locations

U.S. sites
30
U.S. states
13
U.S. cities
21
Facility City State ZIP Site status
Northwest Arkansas Clinical Trials Center, PLLC/Hull Dermatology, PA Rogers Arkansas 72758
Anaheim Clinical Trials, LLC Anaheim California 92801
California Dermatology & Clinical Research Institute Encinitas California 92024
Emil A. Tanghetti, MD dba Center for Dermatology and Laser Surgery Sacramento California 95819
Southern California Dermatology Santa Ana California 92701
Tower Saint John's Imaging Santa Monica California 90403
Clinical Science Institute Santa Monica California 90404
Park Avenue Dermatology Administrative Annex Orange Park Florida 32073
Park Avenue Dermatology Orange Park Florida 32073
Olympian Clinical Research Tampa Florida 33609
Rose Radiology Tampa Florida 33609
Forward Clinical Trials, Inc Tampa Florida 33624
Dundee Dermatology West Dundee Illinois 60118
Dawes Fretzin Clinical Research Group, LLC Indianapolis Indiana 46256
Dawes Fretzin Dermatology Group, LLC Indianapolis Indiana 46256
Psoriasis Treatment Center of Central New Jersey East Windsor New Jersey 08520
The Rockefeller University New York New York 10065
Skin Search of Rochester, Inc. Rochester New York 14623
Investigational Drug Services, UNC Hospitals Chapel Hill North Carolina 27514
UNC Dermatology and Skin Cancer Center Chapel Hill North Carolina 27516
UNC Clinical and Translation Research Center Chapel Hill North Carolina 27599
Lynn Health Science Institute Oklahoma City Oklahoma 73112
Vital Prospects Clinical Research Institute, P.C Tulsa Oklahoma 74136
Health Concepts Rapid City South Dakota 57702
Center for Clinical Studies Houston Texas 77004
Lee Medical Associates, PA San Antonio Texas 78213
Progressive Clinical Research, PA San Antonio Texas 78213
Texas Dermatology and Laser Specialists San Antonio Texas 78218
Virginia Clinical Research, Inc. Norfolk Virginia 23502
Premier Clinical Research Spokane Washington 99202

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 14 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT02969018, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Mar 28, 2019 · Synced Apr 29, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT02969018 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →